Progressive pulmonary fibrosis (PPF) represents one of the most challenging phenotypes within the interstitial lung disease ...

Idiopathic pulmonary fibrosis stands as one of medicine’s most challenging respiratory conditions, gradually transforming healthy lung tissue into stiff, scarred material that severely compromises ...

September has been designated as Pulmonary Fibrosis Awareness Month, a time to raise awareness about this disease, its symptoms, treatment options, and the need for support. Pulmonary fibrosis is a ...

MILAN — The European Respiratory Society (ERS) Congress 2023 dedicated an entire session to the multifaceted challenges and ongoing debates surrounding progressive pulmonary fibrosis (PPF). Renowned ...

The proof-of-concept study also identified key metabolites that correlated with pulmonary fibrosis diagnosis and disease progression. Fibrotic interstitial lung disease is often diagnosed late because ...

The pooled global incidence and prevalence of progressive pulmonary fibrosis appear higher in the US than in Europe and South Korea.

More than 100 therapies for idiopathic pulmonary fibrosis are being developed across the globe. IPF is a chronic and progressive lung disease that affects the tissue surrounding the air sacs in the ...